ATS 2020 Advance Program

3:45 Mindful Movement Therapy for Pulmonary Patients T.T. Von Visger, APRN, CCRN, PCCN, CCNS, CNS, PhD, Buffalo, NY CLINICAL • TRANSLATIONAL CLINICAL TOPICS IN PULMONARY MEDICINE A82 UNDERSTANDING INTERSTITIAL LUNG DISEASE THROUGH MULTI-DIMENSIONAL BIOMARKERS Assembly on Clinical Problems 2:15 p.m. - 4:15 p.m. Target Audience Clinicians and clinician scientists, including fellows, community pulmonologists and academic pulmonologists with interest in clinical and translational interstitial lung disease. Objectives At the conclusion of this session, the participant will be able to: • learn new findings about biomarkers currently being developed in patients with interstitial lung disease; • better differentiate interstitial lung disease subtypes; • improve understanding of the genetic basis of some interstitial lung diseases. This session will introduce and review clinically relevant biomarkers across broad disciplines in patients interstitial lung disease. Biomarkers to be discussed include autoantibodies, HRCT, genomics, transcriptomics, proteomics, telomere biology and the microbiome. This discussion will focus on the clinical utility of biomarkers in ILD, including their use in discriminating ILD subtypes and predicting disease outcomes. Chairing: J. Oldham, MD, MS, Sacramento, CA C.K. Garcia, MD, PhD, New York, NY P.L. Molyneaux, MBBS, BS(Hons), London, United Kingdom 2:15 Clinical Laboratory Testing to Differentiate and Risk Stratify Common ILDs S.K. Danoff, MD, MPH, ATSF, Baltimore, MD 2:35 HRCT as an ILD Biomarker S.L.F. Walsh, MD, PhD, London, United Kingdom 2:55 Genomic and Transcriptomic Biomarkers of IPF Susceptibility and Survival N. Kaminski, MD, ATSF, New Haven, CT 3:15 Circulating Plasma Biomarkers of ILD Outcomes J. Oldham, MD, MS, Sacramento, CA 3:35 Telomere-Based Biomarkers of Survival in ILD C.K. Garcia, MD, PhD, New York, NY 3:55 Microbiome-Based Biomarkers of ILD Susceptibility and Survival P.L. Molyneaux, MBBS, BS(Hons), London, United Kingdom CLINICAL CLINICAL TOPICS IN PULMONARY MEDICINE A83 GREAT CASES: CLINICAL RADIOLOGIC, AND PATHOLOGIC CORRELATIONS BY MASTER PHYSICIANS Council of Chapter Representatives 2:15 p.m. - 4:15 p.m. Target Audience Clinicians in areas of pulmonary and critical care medicine, pediatric pulmonology and critical care medicine, sleep medicine, thoracic surgery, and infectious disease Objectives At the conclusion of this session, the participant will be able to: • integrate the clinical presentation, radiologic, and pathologic findings of 7 challenging cases as an educational experience at the ATS International Conference • understand the clinical reasoning used to determine differential diagnosis by Master Clinicians using a multidisciplinary approach; • describe the pathology and radiology of the presented cases. ATS 2020 • Philadelphia, PA 56 SUNDAY • MAY 17